Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation

Immunology and Cell Biology

Volumn 91, Issue 9, 2013, Pages 568-575

  Vogel, Christoph F A ^a   Wu, Dalei ^a   Goth, Samuel R ^a   Baek, Jaeeun ^a   Lollies, Anna ^a   Domhardt, Rowena ^a   Grindel, Annemarie ^a   Pessah, Isaac N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AhR; chemokines; DC; IDO; NF B RelB; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CHEMOKINE; CHEMOKINE RECEPTOR CCR6; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE LIKE 1; INTERLEUKIN 10; INTERLEUKIN 22; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXYGENASE; PROTEIN DC CK1; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; DNA BINDING; FEMALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-10; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CCR6; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTOR RELB; TRANSCRIPTIONAL ACTIVATION;

EID: 84885459070     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.43     Document Type: Article

References (55)

1. Kerkvliet NI. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int Immunopharmacol 2002; 2: 277-291. (Pubitemid 34075417)
2. Holsapple MP, Morris DL, Wood SC, Snyder NK. 2,3,7,8-tetrachlorodibenzo- p-dioxininduced changes in immunocompetence: possible mechanisms. Annu Rev Pharmacol Toxicol 1991; 31: 73-100. (Pubitemid 21903842)
3. Vogel C, Donat S, Dohr O, Kremer J, Esser C, Roller M et al. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities. Arch Toxicol 1997; 71: 372-382. (Pubitemid 27214470)
4. Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI. Aryl hydrocarbon receptordeficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 2001; 171: 157-164. (Pubitemid 32217666)
5. Marshall NB, Kerkvliet NI. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann N Y Acad Sci 2010; 1183: 25-37.
6. Steinman RM. Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med 2007; 13: 1155-1159. (Pubitemid 47530635)
7. Shih VF, Davis-Turak J, Macal M, Huang JQ, Ponomarenko J, Kearns JD et al. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. Nat Immunol 2012; 13: 1162-1170.
8. Tian Y. Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem Pharmacol 2009; 77: 670-680.
9. Vogel CF, Matsumura F. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem Pharmacol 2009; 77: 734-745.
10. Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, Matsumura F. RelB a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 2007; 21: 2941-2955. (Pubitemid 350223506)
11. Patel RD, Murray IA, Flaveny CA, Kusnadi A, Perdew GH. Ah receptor represses acute-phase response gene expression without binding to its cognate response element. Lab Invest 2009; 89: 695-707.
12. Sulentic CE, Kang JS, Na YJ, Kaminski NE. Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3'alpha immunoglobulin heavy chain enhancer. Toxicology 2004; 200: 235-246. (Pubitemid 38798433)
13. Sekine H, Mimura J, Oshima M, Okawa H, Kanno J, Igarashi K et al. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 2009; 29: 6391-6400.
14. Bankoti J, Rase B, Simones T, Shepherd DM. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol Appl Pharmacol 2010; 246: 18-28.
15. Jin GB, Moore AJ, Head JL, Neumiller JJ, Lawrence BP. Aryl hydrocarbon receptor activation reduces dendritic cell function during influenza virus infection. Toxicol Sci 2010; 116: 514-522.
16. Vogel CF, Goth SR, Dong B, Pessah IN, Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 2008; 375: 331-335.
17. + T cells hyporesponsive to antigen. Toxicol Sci 2003; 74: 74-84. (Pubitemid 36850257)
18. Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 2010; 11: 854-861.
19. Jux B, Kadow S, Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol 2009; 182: 6709-6717.
20. Mezrich JD, Nguyen LP, Kennedy G, Nukaya M, Fechner JH, Zhang X et al. SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. PLoS One 2012; 7: e44547.
21. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453: 65-71. (Pubitemid 351630328)
22. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453: 106-109. (Pubitemid 351630329)
23. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009; 10: 864-871.
24. Lawrence BP, Sherr DH. You AhR what you eat? Nat Immunol 2012; 13: 117-119.
25. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011; 334: 1561-1565.
26. Divanovic S, Sawtell NM, Trompette A, Warning JI, Dias A, Cooper AM et al. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J Infect Dis 2012; 205: 152-161.
27. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002; 297: 1867-1870. (Pubitemid 35024345)
28. Ilchmann A, Krause M, Heilmann M, Burgdorf S, Vieths S, Toda M. Impact of culture medium on maturation of bone marrow-derived murine dendritic cells via the aryl hydrocarbon receptor. Mol Immunol 2012; 51: 42-50.
29. Sibilano R, Frossi B, Calvaruso M, Danelli L, Betto E, Dall'Agnese A et al. The aryl hydrocarbon receptor modulates acute and late mast cell responses. J Immunol 2012; 189: 120-127.
30. Zhou Y, Tung HY, Tsai YM, Hsu SC, Chang HW, Kawasaki H et al. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood 2013; 121: 3195-3204.
31. Aguilera-Montilla N, Chamorro S, Nieto C, Sanchez-Cabo F, Dopazo A, Fernandez-Salguero PM et al. Aryl hydrocarbon receptor contributes to the MEK/ ERK-dependent maintenance of the immature state of human dendritic cells. Blood 2013; 121: e108-e117.
32. Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine- dependent mechanism. Proc Natl Acad Sci USA 2010; 107: 19961-19966.
33. Schulz VJ, van Roest M, Bol-Schoenmakers M, van Duursen MB, van den Berg M, Pieters RH et al. Aryl hydrocarbon receptor activation affects the dendritic cell phenotype and function during allergic sensitization. Immunobiology 2013; 218: 1055-1062.
34. Platzer B, Richter S, Kneidinger D, Waltenberger D, Woisetschlager M, Strobl H. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J Immunol 2009; 183: 66-74.
35. Clark GJ, Gunningham S, Troy A, Vuckovic S, Hart DN. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 1999; 98: 189-196. (Pubitemid 29487639)
36. O'Sullivan BJ, MacDonald KP, Pettit AR, Thomas R. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc Natl Acad Sci USA 2000; 97: 11421-11426.
37. Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 2006; 72: 1161-1179. (Pubitemid 44479741)
38. Allan LL, Sherr DH. Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes. Mol Pharmacol 2005; 67: 1740-1750. (Pubitemid 40594175)
39. O'Sullivan BJ, Pai S, Street S, An X, MacDonald KP, Wong M et al. Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation. J Immunol 2011; 187: 4018.
40. Rohlman D, Pham D, Yu Z, Steppan LB, Kerkvliet NI. Aryl hydrocarbon receptormediated perturbations in gene expression during early stages of CD4(+) T-cell differentiation. Front Immunol 2012; 3: 223.
41. Brembilla NC, Ramirez JM, Chicheportiche R, Sorg O, Saurat JH, Chizzolini C. In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner. PLoS One 2011; 6: e18741.
42. Simonian PL, Wehrmann F, Roark CL, Born WK, O'Brien RL, Fontenot AP. Gammadelta T cells protect against lung fibrosis via IL-22. J Exp Med 2010; 207: 2239-2253.
43. Rani R, Jordan MB, Divanovic S, Herbert DR. IFN-gamma-driven IDO production from macrophages protects IL-4Ralpha-deficient mice against lethality during Schistosoma mansoni infection. Am J Pathol 2012; 180: 2001-2008.
44. Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya M et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat Immunol 2012; 13: 144-151.
45. van der Voort R, Kramer M, Lindhout E, Torensma R, Eleveld D, van Lieshout AW et al. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions. J Leukoc Biol 2005; 77: 739-747. (Pubitemid 40628754)
46. Li K, Anderson KJ, Peng Q, Noble A, Lu B, Kelly AP et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008; 112: 5084-5094.
47. Areschoug T, Gordon S. Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol 2009; 11: 1160-1169.
48. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J Immunol 2003; 170: 2302-2309. (Pubitemid 36245615)
49. Guo C, Yi H, Yu X, Zuo D, Qian J, Yang G et al. In situ vaccination with CD204 genesilenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer. Mol Cancer Ther 2012; 11: 2331-2341.
50. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995; 373: 531-536.
51. Wu L, D'Amico A, Winkel KD, Suter M, Lo D, Shortman K. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998; 6: 839-847. (Pubitemid 29024463)
52. Castiglioni P, Lu C, Lo D, Croft M, Langlade-Demoyen P, Zanetti M et al. CD4 T cell priming in dendritic cell-deficient mice. Int Immunol 2003; 1: 127-136. (Pubitemid 36163775)
53. Tas SW, Vervoordeldonk MJ, Hajji N, Schuitemaker JH, van der Sluijs KF, May MJ et al. Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 2007; 110: 1540-1549. (Pubitemid 47443970)
54. Goth SR, Chu RA, Pessah IN. Oxygen tension regulates the in vitro maturation of GMCSF expanded murine bone marrow dendritic cells by modulating class II MHC expression. J Immunol Methods 2006; 308: 179-191. (Pubitemid 43107964)
55. Vogel CF, Sciullo E, Park S, Liedtke C, Trautwein C, Matsumura F. Dioxin increases C/EBPbeta transcription by activating cAMP/protein kinase A. J Biol Chem2004; 279: 8886-8894. (Pubitemid 38295949)